CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 83 enrolled
Drug / intervention
Rocuronium +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02260258
NCT02260258Phase 2Completed
CompareCT.gov

Neuromuscular Blockade for Post-Cardiac Arrest Care

Beth Israel Deaconess Medical Center·interventional·Posted Oct 9, 2014·Updated Jan 29, 2021

In Brief

A Phase 2 clinical trial evaluating Rocuronium and Normal Saline for Cardiac Arrest. Completed, enrolled 83 participants across 5 sites.

Detailed Summary

The main purpose of this study is to evaluate if neuromuscular blockade improves lactate clearance (and preliminary secondary clinical outcome measures) as compared to usual care in post-cardiac arrest patients undergoing targeted temperature management.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCardiac Arrest
CountriesUnited States
CollaboratorsUniversity of Pittsburgh Medical Center, Brigham and Women's Hospital, University of Alabama at Birmingham, Beaumont Hospital

Timeline

Phase 2CompletedFinished
201520162017201820192020202120222023202420252026
First PostedOct 9, 2014
Enrollment StartOct 1, 2014
Primary CompletionMay 29, 2019
TodayJul 2, 2026
Enrollment to primary: 4.7 yearsPosted 11.7 years ago

Interventions

Rocuroniumdrug

Neuromuscular Blockade

Normal Salinedrug

Normal Saline